申请人:Gilead Sciences, Inc.
公开号:EP3159345A1
公开(公告)日:2017-04-26
Compounds of Formula (IV), as well as pharmaceutically acceptable salts thereof, are disclosed:
The compounds are useful in the treatment of Hepatitis C infections.
本研究公开了式(IV)化合物及其药学上可接受的盐类:
这些化合物可用于治疗丙型肝炎感染。